Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sonal Shad
Observed name:
S. Shad
Institution:
University of California, San Francisco
Observed institution:
University of California, San Francisco
ORCID:
0000-0003-1971-4268
Observed ORCID:
0000-0003-1971-4268
OpenAlex ID:
A5014090120
Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer
2021
·
W. Fraser Symmans
, Christina Yau
, et al.
·
JAMA Oncology
·
112
PDF
Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2−) breast cancer before chemo-endocrine therapy
2021
·
L. Du
, C. Yau
, et al.
·
Annals of Oncology
·
46
PDF
Treatment Efficacy Score—continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials
2022
·
M. Marczyk
, A. Mrukwa
, et al.
·
Annals of Oncology
·
21
PDF
Standardizing Pathologic Evaluation of Breast Carcinoma After Neoadjuvant Chemotherapy
2022
·
Sunati Sahoo
, Gregor Krings
, et al.
·
Archives of Pathology & Laboratory Medicine
·
18
Abstract GS4-07: Assessing prognosis after neoadjuvant therapy: A comparison between anatomic ypAJCC staging, residual cancer burden class and neo-bioscore
2021
·
Marieke EM van der Noordaa
, Christina Yau
, et al.
·
Cancer Research
·
3
Abstract PS4-10: Serial MRI and pathology combined to select candidates for therapy de-escalation in the I-SPY 2 TRIAL
2021
·
Sara J Venters
, Wen Li
, et al.
·
Cancer Research
·
1
DMG-38. Effective targeting of EGFR-driven diffuse midline glioma with X117195, a novel brain-penetrant EGFR-targeting tyrosine kinase inhibitor (TKI)
2025
·
Robert Doherty
, Kelsey Wink
, et al.
·
Neuro-Oncology Pediatrics
HGG-06. Combinatorial targeting of avapritinib-driven MAPK activation in pediatric high-grade glioma
2025
·
Kallen Schwark
, Madeline Miclea
, et al.
·
Neuro-Oncology Pediatrics
Abstract PD13-02: Site of recurrence after neoadjuvant therapy: A multi-center pooled analysis
2021
·
Sonal Shad
, Marieke van der Noordaa
, et al.
·
Cancer Research
Abstract PS4-09: Pathologic features of the inter-regimen biopsy predict response to neoadjuvant therapy in the I-SPY 2 TRIAL
2021
·
Jodi M Carter
, Molly E Klein
, et al.
·
Cancer Research
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer : a multi-center pooled analysis of 5161 patients
2021
·
Christie Yao
, Marie Osdoit
, et al.
Show more works
View as search
Works count:
11
Citation count:
201
H-index:
4
I10-index:
4
Year
Topic
Type
